These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11846001)

  • 1. Immunohistochemical detection of early-stage carcinogenesis of oral leukoplakia by increased DNA-instability and various malignancy markers.
    Iwasa M; Imamura Y; Noriki S; Nishi Y; Kato H; Fukuda M
    Eur J Histochem; 2001; 45(4):333-46. PubMed ID: 11846001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal evolution and progression of 20-methylcholanthrene-induced squamous cell carcinoma of mouse epidermis as revealed by DNA instability and other malignancy markers.
    Hirai K; Kumakiri M; Ueda K; Imamura Y; Noriki S; Nishi Y; Kato H; Fukuda M
    Eur J Histochem; 2001; 45(4):319-32. PubMed ID: 11846000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cancer clones in human gastric adenoma by increased DNA-instability and other biomarkers.
    Sun A; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2003; 47(2):111-22. PubMed ID: 12777206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cancer clones in human colorectal adenoma as revealed by increased DNA instability and other bio-markers.
    Jin Y; Sun A; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2007; 51(1):1-10. PubMed ID: 17548263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
    Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
    Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability; II, Otorhinolaryngeal border-line neoplastic lesions.
    Tsuzuki H; Saito H; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 1994; 38(4):291-302. PubMed ID: 7535126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
    Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
    Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
    Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
    Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of PCNA and p53 protein in some oral tumors.
    Tsuji T; Mimura Y; Wen S; Li X; Kanekawa A; Sasaki K; Shinozaki F
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):221-5. PubMed ID: 7594756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
    Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
    Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
    Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
    Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expression characteristics and clinical significance of candidate molecular markers in vocal cord leukoplakia].
    Cui WX; Xu W; Yang QW; Li YR; Hu R; Cheng LY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):592-596. PubMed ID: 30121997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.